China Updates List of Drugs Eligible for Insurance Reimbursement
(Beijing) — Beijing on Thursday published a new edition of a catalog of drugs eligible for reimbursement under government-backed insurance plans, boosting the number of approved medicines by 15.4% as it updated the list for the first time in seven years.
The new catalog lists 2,535 drugs, up from 2,196 in the previous version, published in 2009, according to a statement on the Ministry of Human Resources and Social Security of the People’s Republic of China website.
Among the drugs in the updated catalog, 1,297 are Western and the other 1,238 are Chinese.
“The 2017 catalog is made up four components: drugs from the previous index, Western medicines, Chinese processed medicines and Chinese unprocessed medicines,” the ministry said in a statement. It added the list was compiled after extensive consultations with various industry experts.
Inclusion on the list can mean big profits for drug companies since their products become available for reimbursement under the government health insurance plans that cover most Chinese citizens.
“This is big news for the industry, and could affect a lot of pharmaceutical company stocks,” said Zhang Jinghan, an analyst at CEBM Group, a subsidiary of Caixin Insight Group. “If you weren’t on the list in the past, you couldn’t get reimbursed. So for companies that got included on the list, this will be big.”
Zhang added that the 15% increase in drugs on the list was generally larger than most industry watchers were expecting, indicating Beijing is moving more aggressively to make a wide range of drugs available to treat the vast majority of Chinese who get their insurance through government plans.
Shares of pharmaceutical companies finished broadly higher on optimism that many would benefit from having new drugs included on the list, bucking a 0.4% decline for the Hang Seng Index in Hong Kong and a 0.3% drop for the Shanghai composite. Fosun Pharmaceutical’s Shanghai shares gained 1.2%, while shares of Hong Kong-listed drug distributor Sinopharm gained 0.6%.
Contact writer: Yang Ge (firstname.lastname@example.org)
Oct 19 06:33 PM
Oct 19 05:35 PM
Oct 19 02:03 PM
Oct 19 12:00 PM
Oct 16 05:59 PM
Oct 16 02:00 PM
Oct 16 01:48 PM
Oct 16 11:24 AM
Oct 15 06:09 PM
- 1China’s GDP Growth Likely Recovered to 5.5% in Third Quarter, Caixin Survey Shows
- 2Related Parties Helped Luckin Coffee Fake 123 Million Transactions
- 3In Depth: Meet the Cheap Chinese Electric Car Selling Twice as Fast as Tesla’s Model 3
- 4Gallery: City of 9 Million Tests Everyone for Covid-19
- 5Four Things to Know About the State’s Role in China’s Private Investment Market
- 1Power To The People: Pintec Serves A Booming Consumer Class
- 2Largest hotel group in Europe accepts UnionPay
- 3UnionPay mobile QuickPass debuts in Hong Kong
- 4UnionPay International launches premium catering privilege U Dining Collection
- 5UnionPay International’s U Plan has covered over 1600 stores overseas